Meag Munich Ergo Kapitalanlagegesellschaft MBH lifted its stake in Agilent Technologies, Inc. (NYSE:A) by 193.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,390 shares of the medical research company’s stock after purchasing an additional 29,917 shares during the quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH’s holdings in Agilent Technologies were worth $2,913,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently modified their holdings of A. Jennison Associates LLC purchased a new position in Agilent Technologies in the 2nd quarter worth approximately $212,000. Commerce Bank purchased a new position in Agilent Technologies in the 2nd quarter worth approximately $1,242,000. Delta Lloyd Asset Management N.V. purchased a new position in Agilent Technologies in the 2nd quarter worth approximately $2,026,000. Prudential Financial Inc. raised its holdings in Agilent Technologies by 2.5% in the 2nd quarter. Prudential Financial Inc. now owns 457,503 shares of the medical research company’s stock worth $27,134,000 after acquiring an additional 11,020 shares during the last quarter. Finally, Cipher Capital LP raised its holdings in Agilent Technologies by 18.1% in the 2nd quarter. Cipher Capital LP now owns 89,523 shares of the medical research company’s stock worth $5,309,000 after acquiring an additional 13,703 shares during the last quarter.
TRADEMARK VIOLATION WARNING: This story was first posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are reading this story on another site, it was stolen and reposted in violation of United States and international trademark & copyright law. The original version of this story can be viewed at https://www.truebluetribune.com/2017/11/14/meag-munich-ergo-kapitalanlagegesellschaft-mbh-has-2-91-million-stake-in-agilent-technologies-inc-a.html.
In related news, insider Dominique Grau sold 13,007 shares of the company’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $62.00, for a total value of $806,434.00. Following the completion of the transaction, the insider now owns 60,098 shares of the company’s stock, valued at approximately $3,726,076. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Didier Hirsch sold 72,545 shares of the company’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $62.38, for a total transaction of $4,525,357.10. The disclosure for this sale can be found here. Insiders sold a total of 165,720 shares of company stock valued at $10,488,739 over the last 90 days.
Shares of Agilent Technologies, Inc. (NYSE:A) opened at $67.13 on Tuesday. The company has a quick ratio of 2.76, a current ratio of 3.22 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $21,600.00, a price-to-earnings ratio of 29.17, a PEG ratio of 2.62 and a beta of 1.28. Agilent Technologies, Inc. has a 12 month low of $42.92 and a 12 month high of $68.67.
Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, topping the consensus estimate of $0.52 by $0.07. The firm had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. Agilent Technologies’s revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the business posted $0.49 EPS. research analysts anticipate that Agilent Technologies, Inc. will post 2.32 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 25th. Stockholders of record on Tuesday, October 3rd were paid a $0.132 dividend. The ex-dividend date was Monday, October 2nd. This represents a $0.53 annualized dividend and a dividend yield of 0.79%. Agilent Technologies’s dividend payout ratio (DPR) is 27.32%.
A number of equities research analysts have weighed in on A shares. Zacks Investment Research lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Monday, October 30th. Morgan Stanley reiterated an “overweight” rating and set a $88.00 target price (up from $86.00) on shares of Agilent Technologies in a research note on Tuesday. Robert W. Baird reiterated a “buy” rating and set a $70.00 target price on shares of Agilent Technologies in a research note on Friday, October 20th. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $68.00 target price on shares of Agilent Technologies in a research note on Tuesday, September 26th. Finally, Cowen and Company reiterated a “hold” rating and set a $65.00 target price on shares of Agilent Technologies in a research note on Thursday, September 28th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $67.98.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.